Browse by all authors Browse By Author ID - Marlton, Paula

Browse Results (91 results found)

Subscribe to the RSS feed for this result setSubscribe to the RSS feed for this result set

Page 1 of 2

Result Pages:    1 2  next › last »

Refine

  Abstract Views File Downloads Thomson Reuters Web of Science Citation Count Scopus Citation Count Altmetric Score
Lane, Steven, Saal, Russell, Mollee, Peter, Jones, Mark, Grigg, Andrew, Taylor, Kerry, Seymour, John, Kennedy, Glen, Williams, Bronwyn, Grimmett, Karen, Griffiths, Vanessa, Gill, Devinder, Hourigan, Matthew and Marlton, Paula (2008) A 1 log rise in RQ-PCR transcript levels defines molecular relapse in core binding factor accute myeloid leukemia and predicts subsequent morphologic relapse. Leukemia & Lymphoma, 49 3: 517-523. doi:10.1080/10428190701817266 147   21 Cited 18 times in Scopus18 0
Middleton, HJ, Mollee, P, Bird, R, Mills, AK, Marlton, P and Gill, D (2005). Accelerated delivery of Rituximab is safe on an out-patient basis.. In: Blood. 47th Annual Meeting of the American-Society-of-Hematology, Atlanta Ga, (274B-274B). Dec 10-13, 2005. 77   0
Liu, P, Tarle, SA, Hajra, A, Claxton, DF, Marlton, P, Freedman, M, Siciliano, MJ and Collins, FS (1993). A Fusion Between Transcription Factor Cbf-Beta-Pebp2-Beta and a Myosin Heavy-Chain Is Generated by the Chromosome-16 Inversion in Acute Myelomonocytic Leukemia M4eo. In: American Journal of Human Genetics. , , (243-243). . 40   0
Tran, Huyen, Brighton, Tim, Grigg, Andrew, McRae, Simon, Dixon, Joanna, Thurley, Daniel, Gandhi, Maher K., Truman, Matt, Marlton, Paula and Catalano, John (2014) A multi-centre, single-arm, open-label study evaluating the safety and efficacy of fixed dose rituximab in patients with refractory, relapsed or chronic idiopathic thrombocytopenic purpura (R-ITP1000 study). British Journal of Haematology, 167 2: 243-251. doi:10.1111/bjh.13029 8   Cited 0 times in Scopus0 0
Green, Michael R., Jardine, Paul, Wood, Peter, Wellwood, Jeremy, Lea, Rod A., Marlton, Paula and Griffiths, Lyn R. (2010) A new method to detect loss of heterozygosity using cohort heterozygosity comparisions. Bmc Cancer, 10 195.1-195.8. doi:10.1186/1471-2407-10-195 34   4 Cited 3 times in Scopus3 0
Roberts, AW, He, S, Bradstock, KF, Hertzberg, MS, Durrant, STS, Ritchie, D, Lewis, ID, Marlton, P, McLachlan, AJ, Yeadon, TM, Busfield, SJ, Barriden, MJ, Davis, R, Hosback, S, Mirosa, D, Biondo, M, Bamford, S, DeWitte, M and Basser, R (2008). A Phase 1 and Correlative Biological Study of CSL360 (anti-CD123 mAb) in AML. In: Blood. 50th Annual Meeting of the American- Society-of-Hematology, San Francisco Ca, (1015-1016). Dec 06-09, 2008. 229   1
Hertzberg, Mark, Matthews, Jane Palfrey, Stone, Janey Malka, Dubosq, Ming-Celine, Grigg, Andrew, Ellis, David, Benson, Warwick, Browett, Peter, Horvath, Noemi, Januszewicz, Henry, Abdi, Ehtesham, Green, Michael, Bonaventura, Anthony, Marlton, Paula, Cannell, Paul and Wolf, Max (2014) A phase III randomized trial of high-dose CEOP+filgrastim versus standard-dose CEOP in patients with non-Hodgkin lymphoma: 10-year follow-up data: Australasian Leukaemia and Lymphoma Group (ALLG) NHL07 trial. American Journal of Hematology, 89 5: 536-541. doi:10.1002/ajh.23684 21   0 Cited 0 times in Scopus0 0
Spencer, A, Seldon, M, Deveridge, SF, McCarthy, N, Marlton, P, Enno, A, Cobcroft, R and Gill, DS (1998). A phase II study of CID therapy and early PBSCT in patients with de Novo multiple myeloma. In: British Journal of Haematology. , , (352-352). . 28   0
Mitchell, Paul I. R., Marlton, Paula, Grigg, Andrew, Seymour, John F., Hertzberg, Mark, Enno, Arno, Herrmann, Richard, Bond, Rodney and Arthur, Chris (2008) A phase II study of liposomal daunorubicin, in combination with cyclophosphamide, vincristine and prednisolone, in elderly patients with previously untreated aggressive non-Hodgkin lymphoma. Leukemia and Lymphoma, 49 5: 924-931. doi:10.1080/10428190802007700 55   5 Cited 6 times in Scopus6 0
Bradstock, Kenneth F., Link, Emma, Collins, Marnie, Di Iulio, Juliana, Lewis, Ian D., Schwarer, Anthony, Enno, Arno, Marlton, Paula, Hahn, Uwe, Szer, Jeff, Cull, Gavin and Seymour, John F. (2014) A randomized trial of prophylactic palifermin on gastrointestinal toxicity after intensive induction therapy for acute myeloid leukaemia. British Journal of Haematology, 167 5: 618-625. doi:10.1111/bjh.13086 10   1 Cited 1 times in Scopus1 0
Saal, RJ, Marlton, PV, Timson, G, Gill, DS, Waugh, M, Springall, F and Iland, H (2004) A rapid RT-PCR screening assay incorporating multiplexed validated control genes for CBF rearrangements at diagnosis in AML. Pathology, 36 4: 335-342. doi:10.1080/0031302042000224593 32   0 0
Tey, S. K., Cobcroft, R., Grimmett, K., Marlton, P., Gill, D. and Mills, A. (2004) A simplified endogenous erythroid colony assay for the investigation of polycythaemia. Clinical and Laboratory Haematology, 26 2: 115-121. doi:10.1111/j.1365-2257.2004.00592.x 156   3 Cited 5 times in Scopus5 0
Herzig, Karen A., Juffs, Helen G., Norris, Debra, Brown, Allison M., Gill, Devinder, Hawley, Carmel M., Cobcroft, Ralph, Petrie, James B., Marlton, Paula, Thomson, Damien, Campbell, Scott B., Nicol, David L. and Johnson, David W. (2003) A single-centre experience of post-renal transplant lymphoproliferative disorder. Transplant International, 16 7: 529-536. doi:10.1007/s00147-003-0596-0 116   23 Cited 27 times in Scopus27 0
Herzig, K., Juffs, H., Brown, A. M., Gill, D., Hawley, C. M., Cobcroft, R., Petrie, J. J., Marlton, P., Rigby, R., Thomson, D., Campbell, S. B., Isbel, N., Nicol, D. L. and Johnson, D. W. (2000). A single centre experience of post-renal transplant lymphoproligerative disorder (PTLD). In: 36th Annual Scientific Meeting - The Australaina & New Zealand Society of Nephrology. , Melbourne, (76). 15-17 March 2000. 63  
Ho, P. Joy, Tay, Lay, Teo, Juliana, Marlton, Paula, Grigg, Andrew, St Pierre, Tim, Brown, Greg, Gervasio, Othon L. and Bowden, Donald K. (2011). A Study of Magnetic Resonance Imaging Assessment of Cardiac and Liver Iron Load in Patients with Haemoglobinopathies, Myelodysplastic Syndromes or Other Anaemias Treated with Deferasirox (the MILE study CICL670AAU01) - Results of An Interim Analysis At a Planned Sample Size Reassessment. In: Blood. 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)/Symposium on the Basic Science of Hemostasis and Thrombosis, San Diego Ca, (1374-1375). Dec 10-13, 2011. 52   0
Grigg, A. P., Bashford, J., Seymour, J. F., Shuttleworth, P., Norris, D., Hertzberg, M., Gill, D., Waugh, M., Saal, R. and Marlton, P. (2005) Autografting followed by rituximab for chemosensitive mantle cell lymphoma: A pilot study and literature review. Leukemia and Lymphoma, 46 6: 851-860. doi:10.1080/10428190500052461 32   1 Cited 4 times in Scopus4 0
Lane, SW, Saal, R, Negus, S, Mollee, P, Mather, M, Gill, D, Mills, AK, Bird, RJ, Hourigan, MJ, Jones, M and Marlton, P (2006). Characterisation and prognostic significance of WT-1 gene expression in acute myeloid leukemia (AML).. In: Blood. 48th Annual Meeting of the American-Society-of-Hematology, Orlando Fl, (655A-655A). Dec 09-12, 2006. 45   0
Marlton, P, Keating, M, Kantarjian, H, Pierce, S, Obrien, S, Freireich, EJ and Estey, E (1995) Cytogenetic and Clinical Correlates in Aml Patients with Abnormalities of Chromosome-16. Leukemia, 9 6: 965-971. 24   61
Claxton, DF, Liu, P, Hsu, HB, Marlton, P, Hester, J, Collins, F, Deisseroth, AB, Rowley, JD and Siciliano, MJ (1994) Detection of Fusion Transcripts Generated by the Inversion 16-Chromosome in Acute Myelogenous Leukemia. Blood, 83 7: 1750-1756. 16   142
Morris, K. L., Tate, J. R., Gill, D., Kennedy, G., Wellwood, J., Marlton, P., Bird, R., Mills, A. K. and Molle, P. (2007) Diagnostic and prognostic utility of the serum free light chain assay in patients with AL amyloidosis. Internal Medicine Journal, 37 7: 456-463. doi:10.1111/j.1445-5994.2007.01368.x 76   18 Cited 24 times in Scopus24 0
Taylor, DL, Kerwick, AM, Elliott, SL, Rodwell, RL, Wright, SJ, Marlton, PV, Veleba, AR and Taylor, KM (1993) Discordant Neutrophil Alkaline-Phosphatase Activity and Cytogenetic Response in Chronic Myeloid-Leukemia Treated with Alpha-Interferon. Pathology, 25 4: 363-366. 16   0
Wolf, M, Matthews, J, Stone, J, Benson, W, Browett, P, Dart, G, Abdi, E, Grigg, A, Ding, J, Gurney, H, Bonaventura, A, Marlton, P, Herrmann, R, Ellis, D and Allg (2000). Dose-intensification does not improve outcome in aggressive non-Hodgkin's lymphoma (NHL). Report of a randomized trial by the Australasian Leukemia and Lymphoma Group (ALLG).. In: Blood. , , (832A-832A). . 38   2
Gill, D., Juffs, H. G., Herzig, K. A., Brown, A. M., Hawley, C. M., Cobcroft, R. G., Petrie, J. J., Marlton, P., Kennedy, G., Thomson, D. B., Campbell, S. B., Nicol, D. L., Norris, D. and Johnson, D. W. (2003) Durable and high rates of remission following chemotherapy in posttransplantation lymphoproliferative disorders after renal transplantation. Transplantation Proceedings, 35 1: 256-257. doi:10.1016/S0041-1345(02)03796-X 46   6 Cited 6 times in Scopus6 0
Thomson, A and Marlton, P (1996) Endoscopic diagnosis of pyriform fossa lymphoma. Canadian Journal of Gastroenterology, 10 7: 447-448. 35   0
Gandhi, M. K., Lambley, E., Duraiswamy, J., Dua, U., Smith, C., Elliott, S., Gill, D., Marlton, P., Seymour, J. and Khanna, R. (2006) Expression of LAG-3 by tumor-infiltrating lymphocytes is coincident with the suppression of latent membrane antigen-specific CD8(+) T-cell function in Hodgkin lymphoma patients. Blood, 108 7: 2280-2289. doi:10.1182/blood-2006-04-015164 65   67 Cited 76 times in Scopus76 3
Marlton, P, McCarthy, C and Taylor, K (1992) Fludarabine-Induced Cytogenetic Remission in Prolymphocytic Leukemia. American Journal of Hematology, 40 1: 71-72. doi:10.1002/ajh.2830400117 24   9 0
Smith, Corey, Cooper, Leanne, Burgess, Melinda, Rist, Michael, Webb, Natasha, Lambley, Eleanore, Tellam, Judy, Marlton, Paula, Seymour, John F., Gandhi, Maher and Khanna, Rajiv (2006) Functional reversion of antigen-specific CD8(+) T cells from patients with Hodgkin lymphoma following in vitro stimulation with recombinant polyepitope. Journal of Immunology, 177 7: 4897-4906. 50   24 Cited 26 times in Scopus26
Liu, P, Tarle, SA, Hajra, A, Claxton, DF, Marlton, P, Freedman, M, Siciliano, MJ and Collins, FS (1993) Fusion Between Transcription Factor Cbf-Beta/pebp2-Beta and a Myosin Heavy-Chain in Acute Myeloid-Leukemia. Science, 261 5124: 1041-1044. doi:10.1126/science.8351518 33   563 3
Gandhi, Maher K., Moll, Guido, Smith, Corey, Dua, Ujjwal, Lambley, Eleanore, Ramuz, Olivier, Gill, Devinder, Marlton, Paula, Seymour, John F. and Khanna, Rajiv (2007) Galectin-1 mediated suppression of Epstein-Barr virus-specific T-cell immunity in classic Hodgkin lymphoma. Blood, 110 4: 1326-1329. doi:10.1182/blood-2007-01-066100 124   61 Cited 71 times in Scopus71 3
Ellis, VM, Cowley, DM, Taylor, KM and Marlton, P (1992) Gamma-Heavy Chain Disease Developing in Association with Myelodysplastic Syndrome. British Journal of Haematology, 81 1: 125-126. doi:10.1111/j.1365-2141.1992.tb08184.x 17   5 0
Gray, J. X., Leo, P. J., Mukhopadhyay, P., Glazov, E. A., Danoy, P.., Donskoi, M., Brown, A., Lewis, I. D., D'Andrea, R. J., Brown, M. A., Marlton, P., Gill, D. S. and Gonda, T. (2010). Genome-wide analysis of genetic alterations in acute myeloid leukaemia (Massively parallel, high-throughput, paired-end DNA sequencing and genotyping of an AML genome). In: 52nd Annual Meeting of the American-Society-of-Hematology (ASH), Orlando, FL, U.S.A., (708-709). 4 - 7 December 2010. 44   0
Vuckovic, S., Kim, M., Turtle, C. J., Khalil, D., Crosbie, G.V., Williams, K., Williams, N., Brown, L., Kelly, C., Stravos, P., Rodwell, R., Hill, G., Wright, S. J., Taylor, K., Gill, D., Marlton, P., Bradstock, K. and Hart, D. N. J. (2003) Granulocyte-colony stimulating factor increases CD123hi blood dendritic cells with altered CD62L and CCR7 expression. Blood, 101 6: 2314-2317. doi:10.1182/blood-2002-03-0973 106   39 Cited 38 times in Scopus38 0
Marlton, PV, Wright, SJ and Taylor, KM (1992) Granulocyte Colony Stimulating Factor in the Management of Chronic Neutropenia. Medical Journal of Australia, 156 10: 729-731. 16   5
Mutsando, Howard, Fahim, Magid, Gill, Devinder S., Hawley, Carmel M., Johnson, David W., Maher, K. Gandhi, Marlton, Paula V., Mar Fan, Helen G. and Mollee, Peter N. (2012) High dose methotrexate and extended hours high-flux hemodialysis for the treatment of primary central nervous system lymphoma in a patient with end stage renal disease. American Journal of Blood Research, 2 1: 66-70. 47 3
Green, Michael, Gandhi, Maher K, Camilleri, Emily, Marlton, Paula, Lea, Rod and Griffiths, Lyn (2009) High levels of BACH2 associated with lower levels of BCL2 transcript abundance in t(14;18)(q21;q34) translocation positive non-Hodgkin's lymphoma. Leukemia Research, 33 5: 731-734. doi:10.1016/j.leukres.2008.09.007 40   7 Cited 7 times in Scopus7 0
Aya-Bonilla, C., Green, M.R., Camilleri, E., Benton, M., Keane, C., Marlton, P., Lea, R., Gandhi, M.K. and Griffiths, L.R. (2013) High-resolution loss of heterozygosity screening implicates PTPRJ as a potential tumor suppressor gene that affects susceptibility to non-hodgkin's lymphoma. Genes Chromosomes and Cancer, 52 5: 467-479. doi:10.1002/gcc.22044 30 4 3 Cited 3 times in Scopus3 1
Camilleri, Emily T., Aya-Bonilla, Carlos A., Brown, Philip J., Banham, Alison, Marlton, Paula, Gandhi, Maher K. and Griffiths, Lyn R. (2012). Identification of FOXP1 Transcriptional Targets in Diffuse Large B Cell Lymphoma. In: Blood. 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Atlanta Ga, (). Dec 08-11, 2012. 5   0
Kennedy, GA, Cull, G, Gill, D, Marlton, P, Norris, D and Cobcroft, R (2002) Identification of tumours with the CD43 only phenotype during the investigation of suspected lymphoma: A heterogeneous group not necessarily of T cell origin. Pathology, 34 1: 46-50. doi:10.1080/00313020120105633 29   4 Cited 3 times in Scopus3 0
Liu, P, Claxton, DF, Marlton, P, Hajra, A, Siciliano, J, Freedman, M, Chandrasekharappa, SC, Yanagisawa, K, Stallings, RL, Collins, FS and Siciliano, MJ (1993) Identification of Yeast Artificial Chromosomes Containing the Inversion 16-P-Arm Breakpoint Associated with Acute Myelomonocytic Leukemia. Blood, 82 3: 716-721. 19   34
Mollee, P, Hourigan, M, Johnson, D, Jones, M, Isabel, N, Hawley, C, Marlton, P, Gandhi, M, Campbell, S and Gill, D (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. In: Blood. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta Ga, (410A-411A). Dec 08-11, 2007. 30   0
Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Ghandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) Can Be Safely Ceased during Chemotherapy for PTLD in Renal Transplant Patients. In: P. Halloran, American Journal of Transplantation: Proceedings of the American Transplant Congress 2007. American Transplant Congress 2007, USA, (399-399). 5-9 May 2007. doi:10.1111/j.1600-6143.2007.01811.x 157   0 0
Hourigan, Matthew J., Johnson, David W., Jones, Mark, Gill, Devinder S., Isbel, Nikki, Hawley, Carmel M., Marlton, Paula, Gandhi, Maher, Campbell, Scott B. and Mollee, Peter (2007). Immunosuppression (IST) can be safely ceased during chemotherapy for PTLD in renal transplant patients. In: American Journal of Transplantation. American Transplant Congress, San Francisco, CA, USA, (399-399). 5-9 May 2007. doi:10.1111/j.1600-6143.2007.01811.x 82   0 0
Kennedy, GA, Tey, SK, Cobcroft, R, Marlton, P, Grimmett, K and Gill, D (2002). Incidence and nature of CD20 negative relapses following rituximab therapy in aggressive B-cell non-Hodgkin's lymphoma: A retrospective review.. In: Blood. 44th Annual Meeting of the American-Society-of-Hematology, Philadelphia Pennsylvania, (360A-360A). Dec 06-10, 2002. 16   0
Kennedy, GA, Tey, SK, Cobcroft, R, Marlton, P, Cull, G, Grimmett, K, Thomson, D and Gill, D (2002) Incidence and nature of CD20-negative relapses following rituximab therapy in aggressive B-cell non-Hodgkin's lymphoma: a retrospective review. British Journal of Haematology, 119 2: 412-416. doi:10.1046/j.1365-2141.2002.03843.x 22   61 Cited 69 times in Scopus69 0
Lane, Steven W., Marlton, Paula and Mollee, Peter N. (2006) Increased Mortality with FLA Compared with ADE Chemotherapy in High-risk AML (Letter to the Editor). Blood, 108 12: 3950-3951. doi:10.1182/blood-2006-06-032680 50   0 Cited 0 times in Scopus0 0
Spencer, A., Seldon, M. R., Deveridge, S., Cobcroft, R. G., Cull, G., Marlton, P., Enno, A. and Gill, D. (2004) Induction with oral chemotherapy (CID) followed by early autologous stem cell transplantation for de novo multiple myeloma patients. The Hematology Journal, 5 3: 216-221. doi:10.1038/sj.thj.6200342 52   9 Cited 8 times in Scopus8 0
Green, Michael R., Aya-Bonilla, Carlos, Gandhi, Maher K., Lea, Rod A., Wellwood, Jeremy, Wood, Peter, Marlton, Paula and Griffiths, Lyn R. (2011) Integrative genomic profiling reveals conserved genetic mechanisms for tumorigenesis in common entities of non-Hodgkin's lymphoma. Genes Chromosomes and Cancer, 50 5: 313-326. doi:10.1002/gcc.20856 55 6 20 Cited 20 times in Scopus20 0
Morschhauser, F, Marlton, P, Vitolo, U, Linden, O, Seymour, J, Crump, M, Coiffier, B, Pulsoni, A, Belch, A, Lerch, E, Kimby, E, Arnljots, K, Wassner, E and Mendila, M (2007). Interim results of a phase I/II study of ocrelizumab, a new humanised Anti-CD20 antibody in patients with relapsed/refractory follicular non-hodgkin's lymphoma. In: Blood. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta Ga, (199A-199A). Dec 08-11, 2007. 54   6
Marlton, P, Saal, R, Gill, D and Cobcroft, R (1998). Inversion (16) is detectable by long range genomic PCR.. In: Blood. , , (73A-73A). . 17   0
Weston, H, Bird, R, Griffiths, V, Jones, M, Grimmett, K, Saal, R, Mills, AK, Gill, D, Marlton, P and Mollee, P (2007). JAK2V617F mutation status predicts thrombotic complications, including arterial thrombosis, in patients with essential thrombocytosis (ET). In: Blood. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta Ga, (752A-752A). Dec 08-11, 2007. 44   0

Page 1 of 2

Result Pages:    1 2  next › last »